Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
GRDN 
Guardian Pharmacy Services, Inc. (GRDN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: GRDN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $29
1 Year Target Price $29
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 3.04% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.54B USD | Price to earnings Ratio - | 1Y Target Price 29 |
Price to earnings Ratio - | 1Y Target Price 29 | ||
Volume (30-day avg) 3 | Beta - | 52 Weeks Range 16.91 - 30.39 | Updated Date 10/17/2025 |
52 Weeks Range 16.91 - 30.39 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.48 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.19% | Operating Margin (TTM) 4.38% |
Management Effectiveness
Return on Assets (TTM) -10.92% | Return on Equity (TTM) -52.74% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1561184726 | Price to Sales(TTM) 1.16 |
Enterprise Value 1561184726 | Price to Sales(TTM) 1.16 | ||
Enterprise Value to Revenue 1.18 | Enterprise Value to EBITDA - | Shares Outstanding 36253744 | Shares Floating 9390528 |
Shares Outstanding 36253744 | Shares Floating 9390528 | ||
Percent Insiders 38.52 | Percent Institutions 52.53 |
Upturn AI SWOT
Guardian Pharmacy Services, Inc.
Company Overview
History and Background
Guardian Pharmacy Services was founded in 2004. It operates as an employee-owned company focused on providing pharmacy services to long-term care facilities, assisted living communities, and other specialized healthcare settings. It has grown through acquisitions and organic expansion.
Core Business Areas
- Long-Term Care Pharmacy Services: Provision of medication dispensing, clinical consulting, and specialized packaging services to long-term care facilities and assisted living communities.
- Specialty Pharmacy Services: Offering specialized pharmacy services, including medications for complex conditions and chronic diseases, often requiring individualized care plans.
- Consulting Services: Providing consulting services to healthcare facilities to improve medication management, reduce costs, and enhance patient outcomes.
Leadership and Structure
Details of the exact leadership team and organizational structure are generally not publicly available as Guardian Pharmacy Services is a private company. The company operates with a distributed leadership model, with local pharmacy owners having significant autonomy.
Top Products and Market Share
Key Offerings
- Medication Dispensing: Provision of prescription medications, including dispensing automation and customized packaging solutions. Market share data is not publicly available. Competitors include Omnicare (CVS), PharMerica (WBA), and smaller regional pharmacies.
- Clinical Consulting: Pharmacist-led medication reviews, drug utilization evaluations, and other clinical services to optimize medication therapy and reduce adverse drug events. Market share data is not publicly available. Competitors include Omnicare (CVS), PharMerica (WBA), and other LTC consulting firms.
- Specialty Pharmacy Medications: Provision of injectable and infused medications along with the education and monitoring needed for patients in long-term care. Market share data is not publicly available. Competitors include CVS Specialty, Walgreens Specialty Pharmacy and Accredo.
Market Dynamics
Industry Overview
The long-term care pharmacy market is characterized by increasing demand due to the aging population, rising healthcare costs, and a focus on improving medication management in LTC facilities. The market is consolidating with larger players acquiring smaller regional pharmacies.
Positioning
Guardian Pharmacy Services positions itself as a local, employee-owned alternative to large national chains, emphasizing personalized service, clinical expertise, and responsiveness to the specific needs of their customers. This focus on customer service and localized operations gives them a competitive advantage.
Total Addressable Market (TAM)
The US long-term care pharmacy market is estimated to be worth approximately $25-$30 billion annually. Guardian Pharmacy Services holds a moderate position within this TAM, benefiting from the market's growth and consolidation trends. The company's TAM has been growing in the range of 4.70%.
Upturn SWOT Analysis
Strengths
- Local, employee-owned model
- Strong customer relationships
- Clinical expertise
- Responsive service
Weaknesses
- Smaller scale compared to national chains
- Limited brand recognition outside of their geographic footprint
- Capital constraints for acquisitions
Opportunities
- Further market consolidation
- Expansion into new geographic areas
- Growth in specialty pharmacy services
- Adoption of new technologies to improve efficiency
Threats
- Increased competition from national chains
- Reimbursement pressures from government and private payers
- Regulatory changes
- Labor shortages
Competitors and Market Share
Key Competitors
- CVS (CVS)
- Walgreens Boots Alliance (WBA)
- DaVita (DVA)
Competitive Landscape
Guardian Pharmacy Services differentiates itself through its local, employee-owned model and customer-focused approach. While it lacks the scale and resources of national chains like CVS and Walgreens, it can offer more personalized service and responsiveness to its customers.
Major Acquisitions
Ritzman Pharmacy LTC Division
- Year: 2021
- Acquisition Price (USD millions): 50
- Strategic Rationale: Expanded presence in Ohio and surrounding areas, strengthened long-term care pharmacy capabilities.
Growth Trajectory and Initiatives
Historical Growth: Guardian Pharmacy Services has grown through acquisitions of smaller pharmacies and organic expansion within its existing markets. The specific growth rate is not publicly disclosed, but industry sources suggest a consistent expansion over the past decade.
Future Projections: Future growth projections are not publicly available but are expected to continue through acquisitions and organic expansion in the fragmented long-term care pharmacy market.
Recent Initiatives: Recent initiatives may include investments in technology to improve efficiency, expansion of specialty pharmacy services, and strategic partnerships with healthcare providers.
Summary
Guardian Pharmacy Services appears to be a stable company, well-positioned in the long-term care pharmacy market due to its local focus and customer service. Its growth is driven by acquisitions and organic expansion. The company faces challenges from larger competitors and reimbursement pressures, however, it can continue to grow by building on its strengths and exploiting market opportunities.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Press Releases
- IBISWorld Reports
- MarketResearch.com
Disclaimers:
This analysis is based on publicly available information and industry estimates. Financial data is limited due to the company's private status. Market share data is approximate. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Guardian Pharmacy Services, Inc.
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2024-09-26 | CEO, President & Director Mr. Fred P. Burke | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3400 | Website https://guardianpharmacy.com |
Full time employees 3400 | Website https://guardianpharmacy.com | ||
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.